"Beauty is a light in the heart": the transformative potential of optogenetics for clinical applications in cardiovascular medicine.

Optogenetics is an exciting new technology in which viral gene or cell delivery is used to inscribe light sensitivity in excitable tissue to enable optical control of bioelectric behavior. Initial progress in the fledgling domain of cardiac optogenetics has included in vitro expression of various light-sensitive proteins in cell monolayers and transgenic animals to demonstrate an array of potentially useful applications, including light-based pacing, silencing of spontaneous activity, and spiral wave termination. In parallel to these developments, the cardiac modeling community has developed a versatile computational framework capable of realistically simulating optogenetics in biophysically detailed, patient-specific representations of the human heart, enabling the exploration of potential clinical applications in a predictive virtual platform. Toward the ultimate goal of assessing the feasibility and potential impact of optogenetics-based therapies in cardiovascular medicine, this review provides (1) a detailed synopsis of in vivo, in vitro, and in silico developments in the field and (2) a critical assessment of how existing clinical technology for gene/cell delivery and intra-cardiac illumination could be harnessed to achieve such lofty goals as light-based arrhythmia termination.

[1]  Yaqin Xu,et al.  A single direct injection into the left ventricular wall of an adeno‐associated virus 9 (AAV9) vector expressing extracellular superoxide dismutase from the cardiac troponin‐T promoter protects mice against myocardial infarction , 2011, The journal of gene medicine.

[2]  P. Moriña-Vázquez,et al.  Ventricular resynchronization therapy by direct His-bundle pacing using an internal cardioverter defibrillator. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[3]  Bin Zhou,et al.  Stem cell engraftment and survival in the ischemic heart. , 2011, The Annals of thoracic surgery.

[4]  S. Acton,et al.  Robust Cardiomyocyte-Specific Gene Expression Following Systemic Injection of AAV: In Vivo Gene Delivery Follows a Poisson Distribution , 2010, Gene Therapy.

[5]  T. Bruegmann,et al.  Optogenetic control of heart muscle in vitro and in vivo , 2010, Nature Methods.

[6]  M. Rosen,et al.  Finding Fluorescent Needles in the Cardiac Haystack: Tracking Human Mesenchymal Stem Cells Labeled with Quantum Dots for Quantitative In Vivo Three‐Dimensional Fluorescence Analysis , 2007, Stem cells.

[7]  D. Kleinfeld,et al.  ReaChR: A red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation , 2013, Nature Neuroscience.

[8]  Yei Hwan Jung,et al.  Injectable, Cellular-Scale Optoelectronics with Applications for Wireless Optogenetics , 2013, Science.

[9]  L. Gepstein,et al.  Modulation of cardiac tissue electrophysiological properties with light-sensitive proteins. , 2014, Cardiovascular research.

[10]  Blanca Rodriguez,et al.  Synthesis of voltage-sensitive optical signals: application to panoramic optical mapping. , 2006, Biophysical journal.

[11]  G. Plank,et al.  Simulating photon scattering effects in structurally detailed ventricular models using a Monte Carlo approach , 2014, Front. Physiol..

[12]  R. Bonow,et al.  Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). , 2014, Journal of the American College of Cardiology.

[13]  Karl Deisseroth,et al.  Multiscale computational models for optogenetic control of cardiac function. , 2011, Biophysical journal.

[14]  Harold Bien,et al.  Stimulating Cardiac Muscle by Light: Cardiac Optogenetics by Cell Delivery , 2011, Circulation. Arrhythmia and electrophysiology.

[15]  Ernst Bamberg,et al.  Spectral characteristics of the photocycle of channelrhodopsin-2 and its implication for channel function. , 2008, Journal of molecular biology.

[16]  K. Deisseroth,et al.  Millisecond-timescale, genetically targeted optical control of neural activity , 2005, Nature Neuroscience.

[17]  Feng Zhang,et al.  Channelrhodopsin-2 and optical control of excitable cells , 2006, Nature Methods.

[18]  A. Strickberger,et al.  Comparison of ICD Implantation in Obese and Nonobese Patients , 2014, Pacing and clinical electrophysiology : PACE.

[19]  Patrick Degenaar,et al.  Photocycles of Channelrhodopsin‐2 , 2009, Photochemistry and photobiology.

[20]  Yasushi Miyashita,et al.  Optogenetic Manipulation of Cerebellar Purkinje Cell Activity In Vivo , 2011, PloS one.

[21]  Jens Jung,et al.  Defibrillation Efficacy and Pain Perception of Two Biphasic Waveforms for Internal Cardioversion of Atrial Fibrillation , 2003, Journal of cardiovascular electrophysiology.

[22]  D. T. Yue,et al.  Optical mapping of optogenetically shaped cardiac action potentials , 2014, Scientific Reports.

[23]  Daniel R. Merrill,et al.  Electrical stimulation of excitable tissue: design of efficacious and safe protocols , 2005, Journal of Neuroscience Methods.

[24]  John C. Williams,et al.  Computational Optogenetics: Empirically-Derived Voltage- and Light-Sensitive Channelrhodopsin-2 Model , 2013, PLoS Comput. Biol..

[25]  Michael Z. Lin,et al.  Toward the Second Generation of Optogenetic Tools , 2010, The Journal of Neuroscience.

[26]  S. F. Mironov,et al.  Visualizing excitation waves inside cardiac muscle using transillumination. , 2001, Biophysical journal.

[27]  Aleksandra Klimas,et al.  Cardiac applications of optogenetics. , 2014, Progress in biophysics and molecular biology.

[28]  J. K. Donahue,et al.  Targeted Modification of Atrial Electrophysiology by Homogeneous Transmural Atrial Gene Transfer , 2005, Circulation.

[29]  T. Weber,et al.  Gene Therapy for Heart Failure , 2012, Circulation research.

[30]  Yonggang Huang,et al.  Waterproof AlInGaP optoelectronics on stretchable substrates with applications in biomedicine and robotics. , 2010, Nature materials.

[31]  Charles E. Murry,et al.  Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate Non-Human Primate Hearts , 2014, Nature.

[32]  Aristides B. Arrenberg,et al.  Optogenetic Control of Cardiac Function , 2010, Science.

[33]  Stefan R. Pulver,et al.  Independent Optical Excitation of Distinct Neural Populations , 2014, Nature Methods.

[34]  Joshua M Hare,et al.  Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. , 2012, JAMA.

[35]  Thomas V. Karathanos,et al.  Optogenetics-enabled dynamic modulation of action potential duration in atrial tissue: feasibility of a novel therapeutic approach. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[36]  N. Trayanova,et al.  Advances in modeling ventricular arrhythmias: from mechanisms to the clinic , 2014, Wiley interdisciplinary reviews. Systems biology and medicine.

[37]  Edward S Boyden,et al.  Optogenetics and Translational Medicine , 2013, Science Translational Medicine.

[38]  Philipp Sasse,et al.  Optogenetic activation of Gq signalling modulates pacemaker activity of cardiomyocytes. , 2014, Cardiovascular research.

[39]  D. Ypey,et al.  Light-induced termination of spiral wave arrhythmias by optogenetic engineering of atrial cardiomyocytes. , 2014, Cardiovascular research.

[40]  E. Entcheva,et al.  Channelrhodopsin2 Current During the Action Potential: “Optical AP Clamp” and Approximation , 2014, Scientific Reports.

[41]  Natalia A Trayanova,et al.  See the light: can optogenetics restore healthy heartbeats? And, if it can, is it really worth the effort? , 2014, Expert review of cardiovascular therapy.

[42]  Kyung-In Jang,et al.  3D multifunctional integumentary membranes for spatiotemporal cardiac measurements and stimulation across the entire epicardium , 2014, Nature Communications.

[43]  E. Bamberg,et al.  Channelrhodopsin-2, a directly light-gated cation-selective membrane channel , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Oscar J. Abilez,et al.  Cardiac optogenetics , 2012, 2012 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[45]  Natalia A Trayanova,et al.  A comprehensive multiscale framework for simulating optogenetics in the heart , 2013, Nature Communications.

[46]  Jason Chung,et al.  Long-term channelrhodopsin-2 (ChR2) expression can induce abnormal axonal morphology and targeting in cerebral cortex , 2013, Front. Neural Circuits.